Integrated Multiomics Analysis Identifies CDO1 as a Novel Therapeutic Target for Osteoarthritis
CDO1 is a novel OA risk gene and therapeutic target. Its inhibition protects against OA progression, as supported by integrated multi-omics analysis and in vivo validation.
Authors
- Duan Wang (ORCID: https://orcid.org/0000-0001-5487-4414)
- Xiangdong Wu (ORCID: https://orcid.org/0000-0002-3920-4372)
- Zhihu Zhao (ORCID: https://orcid.org/0000-0001-7081-8914)
- Wei Luo (ORCID: https://orcid.org/0000-0002-8845-903X)
- Xinlong Ma
- Jianxiong Ma (ORCID: https://orcid.org/0000-0001-6346-6316)
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Sichuan University (CN)
- Beijing Jishuitan Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Tianjin Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-09-25
- DOI
- https://doi.org/10.2174/0118715303387442250918111006
- Citations
- 1
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 1.05